MX9603920A - Derivado de quinolona para el tratamiento de incontinencia urinaria. - Google Patents
Derivado de quinolona para el tratamiento de incontinencia urinaria.Info
- Publication number
- MX9603920A MX9603920A MX9603920A MX9603920A MX9603920A MX 9603920 A MX9603920 A MX 9603920A MX 9603920 A MX9603920 A MX 9603920A MX 9603920 A MX9603920 A MX 9603920A MX 9603920 A MX9603920 A MX 9603920A
- Authority
- MX
- Mexico
- Prior art keywords
- urinary incontinence
- treatment
- quinolone derivative
- quinolone
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describa la (S)-(-)-4-(3-cianofenil)2-trifluorometil-4,6,7,8-t etrahidro-5(1H)quinolona como un abridor de los canales de potasio, util para el tratamiento de incontinencia urinaria, y los procesos para la preparacion del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9407432A GB9407432D0 (en) | 1994-04-14 | 1994-04-14 | Heterocyclic derivative |
PCT/GB1995/000845 WO1995028388A1 (en) | 1994-04-14 | 1995-04-13 | Quinolone derivative for treatment of urinary incontinence |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603920A true MX9603920A (es) | 1997-04-30 |
Family
ID=10753541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603920A MX9603920A (es) | 1994-04-14 | 1995-04-13 | Derivado de quinolona para el tratamiento de incontinencia urinaria. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0755382B1 (es) |
JP (1) | JP3782445B2 (es) |
KR (1) | KR100344885B1 (es) |
CN (1) | CN1058708C (es) |
AT (1) | ATE202089T1 (es) |
AU (1) | AU700773B2 (es) |
BR (1) | BR9507366A (es) |
CA (1) | CA2187525C (es) |
CZ (1) | CZ284652B6 (es) |
DE (1) | DE69521310T2 (es) |
DK (1) | DK0755382T3 (es) |
ES (1) | ES2159633T3 (es) |
FI (2) | FI114705B (es) |
GB (1) | GB9407432D0 (es) |
GR (1) | GR3036482T3 (es) |
HK (1) | HK1013999A1 (es) |
HU (1) | HU215387B (es) |
MX (1) | MX9603920A (es) |
NO (1) | NO307177B1 (es) |
NZ (1) | NZ283779A (es) |
PL (2) | PL183095B1 (es) |
PT (1) | PT755382E (es) |
RU (1) | RU2149870C1 (es) |
SK (1) | SK281124B6 (es) |
WO (1) | WO1995028388A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60036476T2 (de) * | 1999-08-03 | 2008-06-12 | Abbott Laboratories, Abbott Park | Kalium kanalaktivatoren |
EP1307429B1 (en) * | 2000-08-02 | 2007-11-28 | AstraZeneca AB | Process for asymmetric synthesis of substituted 1,4-dihydropyridines |
SE0200205D0 (sv) * | 2002-01-24 | 2002-01-24 | Astrazeneca Ab | Method |
CN102532015B (zh) * | 2012-01-18 | 2013-10-23 | 云南大学 | 香豆素及其类似物的固相合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
-
1994
- 1994-04-14 GB GB9407432A patent/GB9407432D0/en active Pending
-
1995
- 1995-04-13 MX MX9603920A patent/MX9603920A/es not_active IP Right Cessation
- 1995-04-13 BR BR9507366A patent/BR9507366A/pt not_active IP Right Cessation
- 1995-04-13 PL PL95343448A patent/PL183095B1/pl not_active IP Right Cessation
- 1995-04-13 EP EP95915256A patent/EP0755382B1/en not_active Expired - Lifetime
- 1995-04-13 CN CN95192577A patent/CN1058708C/zh not_active Expired - Fee Related
- 1995-04-13 RU RU96119966/04A patent/RU2149870C1/ru active
- 1995-04-13 PT PT95915256T patent/PT755382E/pt unknown
- 1995-04-13 KR KR1019960705672A patent/KR100344885B1/ko not_active IP Right Cessation
- 1995-04-13 ES ES95915256T patent/ES2159633T3/es not_active Expired - Lifetime
- 1995-04-13 SK SK1317-96A patent/SK281124B6/sk not_active IP Right Cessation
- 1995-04-13 DE DE69521310T patent/DE69521310T2/de not_active Expired - Fee Related
- 1995-04-13 PL PL95316790A patent/PL182031B1/pl not_active IP Right Cessation
- 1995-04-13 CA CA002187525A patent/CA2187525C/en not_active Expired - Fee Related
- 1995-04-13 NZ NZ283779A patent/NZ283779A/en not_active IP Right Cessation
- 1995-04-13 WO PCT/GB1995/000845 patent/WO1995028388A1/en active IP Right Grant
- 1995-04-13 AT AT95915256T patent/ATE202089T1/de not_active IP Right Cessation
- 1995-04-13 DK DK95915256T patent/DK0755382T3/da active
- 1995-04-13 HU HU9602747A patent/HU215387B/hu not_active IP Right Cessation
- 1995-04-13 CZ CZ962981A patent/CZ284652B6/cs not_active IP Right Cessation
- 1995-04-13 AU AU22199/95A patent/AU700773B2/en not_active Ceased
- 1995-04-13 JP JP52680695A patent/JP3782445B2/ja not_active Expired - Fee Related
-
1996
- 1996-10-07 FI FI964019A patent/FI114705B/fi active
- 1996-10-11 NO NO964345A patent/NO307177B1/no not_active IP Right Cessation
-
1998
- 1998-12-24 HK HK98115420A patent/HK1013999A1/xx not_active IP Right Cessation
-
2001
- 2001-08-31 GR GR20010401341T patent/GR3036482T3/el not_active IP Right Cessation
-
2004
- 2004-03-04 FI FI20040352A patent/FI115630B/fi active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL318100A1 (en) | 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application | |
NL300433I1 (en) | Methods and compositions for the treatment of glomerulonephritis | |
IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
IL128877A0 (en) | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias | |
AU6289196A (en) | A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection | |
DE59700356D1 (en) | Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid und n-(4-trifluormethylphenyl)-2-cyan-3-hydroxycrotonsäureamid | |
AUPM761094A0 (en) | Treatment of hides | |
AU3115595A (en) | Pyridylthio compounds for controlling helicobacter bacteria | |
MX9603920A (es) | Derivado de quinolona para el tratamiento de incontinencia urinaria. | |
AU6817696A (en) | Herbicidal synergistic composition, and method of controlling weeds | |
AU2600299A (en) | Compositions and methods of treating keratin-related disorders and conditions | |
BG105120A (en) | Chemotaxis-inhibiting protein of staphylococcus (chips) and its use | |
CA2282682A1 (en) | Tazarotene and corticosteroid treatment for psoriasis | |
AU3848797A (en) | Process and composition for the antiparasitic treatment of the surroundings of animals | |
AU4882897A (en) | Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use | |
UA42749C2 (uk) | N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування | |
ZA974386B (en) | New formulation for treatment of thromboembolism. | |
AU2422199A (en) | Ustilipides, method for the production and the use thereof | |
WO1998014567A3 (en) | Methods and compositions for inhibiting bacterial growth | |
AU2358301A (en) | Glyoxyl acid amides | |
AU3247995A (en) | Treatment of hides | |
MX9709450A (es) | Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos. | |
EP0663211A4 (en) | AGENT FOR PREVENTION AND TREATMENT OF DIGESTIVE APPARATUS MUCOUS DISORDERS. | |
AU3974597A (en) | Composition, process and method for treating grass by foliar application | |
AUPM649094A0 (en) | Apparatus for treatment of hides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HC | Change of company name or juridical status |
Owner name: 3M INNOVATIVE PROPERTIES COMPANY.* |
|
PD | Change of proprietorship |
Owner name: ASTRAZENECA UK LIMITED |
|
MM | Annulment or lapse due to non-payment of fees |